A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have ...
Scientists have long known that inherited neurodegenerative disorders, including Alzheimer's, Parkinson's or motor neuron ...
Huntington's disease symptom control relies on medications for involuntary movements, mood, and psychiatric symptoms, but ...
We existed in our own world that day, absorbing information we never wanted to learn. At one point, while I was crying ...
Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
WASHINGTON, DC, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- The journey of helping a child find their voice is ...
As Kool & the Gang's "Celebration" played outside, children from the Special Learning Center's SKIP Clinic paraded out of it ...
SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
No one ever said that working with children with autism, ADHD, or sensory disorders is easy. Theo will only eat white foods, tends to be buried in his own world and melts when he is transitioned too ...
Abivax surged 1,470% YTD, driven by Obefazimod's clinical progress and takeover speculation, but I rate it Hold due to valuation risk. Obefazimod, a first-in-class oral therapy for ulcerative colitis, ...
What Is Myqorzo, and Why Does It Matter? Myqorzo (aficamten) is a new oral medicine approved by the FDA for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). It relieves symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback